Clinical Research Directory
Browse clinical research sites, groups, and studies.
UPRIGHT-PRO: Prospective Development Study of Upright Proton Therapy
Sponsor: Stanford University
Summary
This study is being done to evaluate whether cancer patients can safely and reliably receive proton radiation therapy while positioned upright. Proton therapy is an established form of radiation treatment, and the upright treatment system used in this study has been cleared by the U.S. Food and Drug Administration. The intent of this protocol is to observe the treatment methods, doses, and outcomes for the initial cohorts of patients treated with this upright device. This study will support research activities and evaluate feasibility as needed. Results of this study will be reported in the scientific literature but the investigators do not intend to report to the FDA for a new use or indication or change to the labeling; nor are the investigators required to do so.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
450
Start Date
2026-09
Completion Date
2027-09
Last Updated
2026-07-16
Healthy Volunteers
No
Conditions
Interventions
Standard-of-Care Proton Therapy
Participants receive standard-of-care proton therapy at Stanford. Treatment is not assigned by the study.
Locations (2)
Lucile Packard Children's Hospital Stanford
Palo Alto, California, United States
Stanford University
Palo Alto, California, United States